Tetra-sulfonate phthalocyanine zinc-bovine serum albumin conjugate-mediated photodynamic therapy of human glioma

Journal of Biomaterials Applications

Volumn 29, Issue 3, 2014, Pages 378-385

  Xu, Dianshuang ^a   Chen, Xiangyu ^b   Chen, Ke'En ^a   Peng, Yiru ^c   Li, Yingxin ^d   Ke, Yiquan ^e   Gan, Danhui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c FUJIAN NORMAL UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; glioma; photodynamic therapy; VEGF

Indexed keywords

BIOLOGICAL MATERIALS; BLOOD VESSELS; CELL DEATH; CELL ENGINEERING; CHEMOTHERAPY; DIAGNOSIS; ENDOTHELIAL CELLS; MAMMALS; PHOTODYNAMIC THERAPY; TUMORS;

GLIOMA; IMMUNOHISTOCHEMISTRY; MICROVESSEL DENSITY; PHOTODYNAMIC THERAPY (PDT); THERAPEUTIC EFFECTS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

PHOTOSENSITIZERS;

BOVINE SERUM ALBUMIN; RADIOSENSITIZING AGENT; TETRASULFONATE PHTHALOCYANINE ZINC; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC DERIVATIVE; INDOLE DERIVATIVE; PHTHALOCYANINE; SULFONIC ACID DERIVATIVE; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CAPILLARY DENSITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR VOLUME; XENOGRAFT; ANIMAL; BRAIN NEOPLASMS; CHEMISTRY; NUDE MOUSE;

ANIMALS; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; INDOLES; MICE; MICE, NUDE; SERUM ALBUMIN, BOVINE; SULFONIC ACIDS; ZINC;

EID: 84906654051     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328214529466     Document Type: Article

References (31)

1. http://publications.cancerresearchuk.org/publicationformat/data-tables/ dtcasesdeaths.html.
2. Madsen SJ, Mathews MS, Angell-Petersen E, et al. Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated photodynamic therapy in human glioma spheroids. J Neuro Oncol. 2009 ; 91: 141-149
3. Kostron H, Obwegeser A, Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B. 1996 ; 36: 157-168
4. Kanu OO, Mehta A, Di C, et al. Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets. 2009 ; 13: 701-718
5. Misra A, Ganesh S, Shahiwala A, et al. Drug delivery to the central nervous system: a review. J Pharm Sci. 2003 ; 6: 252-273
6. Lesniak MS, Langer R, Brem H. Drug delivery to tumors of the central nervous system. Curr Neurol Neurosci Rep. 2001 ; 1: 210-216
7. Maduray K, Karsten A, Odhav B, et al. In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy. J Photochem Photobiol B. 2011 ; 103: 98-104
8. Plaetzer K, Krammer B, Berlanda J, et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Laser Med Sci. 2009 ; 24: 259-268
9. Triesscheijn M, Baas P, Schellens JHM, et al. Photodynamic therapy in oncology. Oncologist. 2006 ; 11: 1034-1044
10. Allen CM, Sharman WM, Van Lier JE. Current status of phthalocynanines in the photodynamic therapy of cancer. J Porphyr Phthalocyanines. 2001 ; 5: 161-169
11. Ogunsipe A, Durmus M, Atilla D, et al. Synthesis, photophysical and photochemical studies on long chain zinc phythalocyanines. Synthetic Metal. 2008 ; 158: 839-847
12. Rossetti FC, Lopes LB, Carollo AR, et al. A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy. J Control Release. 2011 ; 155: 400-408
13. Xu D, Ke Y, Jiang X, et al. In vitro photodynamic therapy on human U251 glioma cells with a novel photosensitiser ZnPcS4-BSA. Br J Neurosurg. 2010 ; 24: 660-665
14. Huang Y, Xu G, Peng Y, et al. Photodynamic effects of ZnPcS4-BSA in human retinal pigment epithelium cells. J Ocul Pharmacol Ther. 2009 ; 25: 231-238
15. Bai CZ, Choi S, Nam K, et al. Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma. Int J Pharm. 2013 ; 445: 79-87
16. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003 ; 3: 380-387
17. Snyder JW, Greco WR, Bellnier DA, et al. Photodynamic therapy: a means to enhanced drug delivery to tumors. Cancer Res. 2003 ; 63: 8126-8131
18. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci. 2002 ; 17: 173-186
19. Aarts F, Bleichrodt RP, Oyen WJ, et al. Intracavitary radioimmunotherapy to treat solid tumors. Cancer Biother Radiopharm. 2008 ; 23: 92-107
20. Thomas N, Tirand L, Chatelut E, et al. Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice. Photochem Photobiol Sci. 2008 ; 7: 433-441
21. Sanovic R, Krammer B, Grumboeck S, et al. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin. Int J Oncol. 2009 ; 35: 921-939
22. Lu SL, Zhang WC, Akiyama Y, et al. Genomic structure of the transforming growth factor beta type II receptor gene and its mutmions in hereditary nonpolyposis colorectal cancers. Cancer Res. 1996 ; 56: 4595-4598
23. Nicco C, Laurent A, Chereau C, et al. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother. 2005 ; 59: 169-174
24. Ventura A, Luzi L, Pacini S, et al. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J Biol Chem. 2002 ; 277: 22370-22376
25. Xiao D, Singh SV. p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells. Cancer Res. 2010 ; 70: 3150-3158
26. Bhuvaneswari R, Gan YY, Soo KC, et al. The effect of photodynamic therapy on tumor angiogenesis. Cell Mol Life Sci. 2009 ; 66: 2275-2283
27. Xie Y, Wei ZB, Zhang Z, et al. Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice. Oncol Rep. 2009 ; 22: 1365-1371
28. Bhuvaneswari R, Yuen GY, Chee SK, et al. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins. Photochem Photobiol Sci. 2007 ; 6: 1275-1283
29. Das R, Jahr H, van Osch G, et al. The role of hypoxia in MSCs: Considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2010 ; 16: 159-168
30. Chen L, Zhang Y, Yang J, et al. Vertebrate animal models of glioma: understanding the mechanisms and developing new therapies. Biochim Biophys Acta. 2013 ; 1836: 158-165
31. Stummer W, Götz C, Hassan A, et al. Kinetics of Photofrin II in perifocal brain edema. Neurosurgery. 1993 ; 33: 1075-1081